Global Peptide Index
Get weekly changes

COMPANY

NOVO NORDISK CANADA INC

NOVO NORDISK CANADA INC: marketing authorisation holder for Glucagon, Insulin degludec, Liraglutide, Semaglutide, as stated by public registers.

MARKETING AUTHORISATION HOLDER

Holds the licence to sell the medicine in a country (EMA, MHRA, Health Canada).

GlucagonGLUCAGEN (DIN 02333619), Cancelled Post Market Regulator Health Canada
GlucagonGLUCAGEN HYPOKIT (DIN 02333627), Cancelled Post Market Regulator Health Canada
Insulin degludecTRESIBA (DIN 02467860), Marketed Regulator Health Canada
Insulin degludecTRESIBA (DIN 02467879), Marketed Regulator Health Canada
Insulin degludecTRESIBA (DIN 02467887), Marketed Regulator Health Canada
Insulin degludecXULTOPHY (DIN 02474875), Cancelled Post Market Regulator Health Canada
LiraglutideSAXENDA (DIN 02437899), Marketed Regulator Health Canada
LiraglutideVICTOZA (DIN 02351064), Marketed Regulator Health Canada
SemaglutideOZEMPIC (DIN 02471469), Marketed Regulator Health Canada
SemaglutideOZEMPIC (DIN 02471477), Dormant Regulator Health Canada
SemaglutideOZEMPIC (DIN 02523930), Approved Regulator Health Canada
SemaglutideOZEMPIC (DIN 02540258), Marketed Regulator Health Canada
SemaglutideOZEMPIC (DIN 02562618), Approved Regulator Health Canada
SemaglutideOZEMPIC (DIN 02562626), Approved Regulator Health Canada
SemaglutidePLOSBRIO (DIN 02564041), Approved Regulator Health Canada
SemaglutidePLOSBRIO (DIN 02564068), Approved Regulator Health Canada
SemaglutidePLOSBRIO (DIN 02564076), Approved Regulator Health Canada
SemaglutidePLOSBRIO (DIN 02564084), Approved Regulator Health Canada
SemaglutidePLOSBRIO (DIN 02568233), Approved Regulator Health Canada
SemaglutidePLOSBRIO (DIN 02568241), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564106), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564114), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564122), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564130), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564149), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564157), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564165), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564173), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564181), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564203), Approved Regulator Health Canada
SemaglutidePOVIZTRA (DIN 02564211), Approved Regulator Health Canada
SemaglutideRYBELSUS (DIN 02497581), Marketed Regulator Health Canada
SemaglutideRYBELSUS (DIN 02497603), Marketed Regulator Health Canada
SemaglutideRYBELSUS (DIN 02497611), Marketed Regulator Health Canada
SemaglutideRYBELSUS (DIN 02551012), Marketed Regulator Health Canada
SemaglutideRYBELSUS (DIN 02551020), Marketed Regulator Health Canada
SemaglutideRYBELSUS (DIN 02551039), Marketed Regulator Health Canada
SemaglutideWEGOVY (DIN 02522551), Approved Regulator Health Canada
SemaglutideWEGOVY (DIN 02522578), Approved Regulator Health Canada
SemaglutideWEGOVY (DIN 02522586), Approved Regulator Health Canada
SemaglutideWEGOVY (DIN 02522594), Approved Regulator Health Canada
SemaglutideWEGOVY (DIN 02522608), Approved Regulator Health Canada
SemaglutideWEGOVY (DIN 02528509), Marketed Regulator Health Canada
SemaglutideWEGOVY (DIN 02528517), Marketed Regulator Health Canada
SemaglutideWEGOVY (DIN 02528525), Marketed Regulator Health Canada
SemaglutideWEGOVY (DIN 02528533), Marketed Regulator Health Canada
SemaglutideWEGOVY (DIN 02528541), Marketed Regulator Health Canada
SemaglutideWEGOVY (DIN 02552698), Marketed Regulator Health Canada

What a register states, not an endorsement or an accusation by this site. All companies.

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.